Influence of Extracellular RNAs, Released by Rheumatoid Arthritis Synovial Fibroblasts, on Their Adhesive and Invasive Properties.
Birgit Zimmermann-GellerSina KöppertSilvia FischerHector Alejandro Cabrera-FuentesStephanie LefèvreMarkus RickertJürgen SteinmeyerStefan RehartThomas UmscheidMarkus SchönburgUlf Müller-LadnerKlaus T PreissnerKlaus W FrommerElena NeumannPublished in: Journal of immunology (Baltimore, Md. : 1950) (2016)
Extracellular RNA (exRNA) has been characterized as a molecular alarm signal upon cellular stress or tissue injury and to exert biological functions as a proinflammatory, prothrombotic, and vessel permeability-regulating factor. In this study, we investigated the contribution of exRNA and its antagonist RNase1 in a chronic inflammatory joint disease, rheumatoid arthritis (RA). Upon immunohistochemical inspection of RA, osteoarthritis (OA), and psoriatic arthritis synovium, exRNA was detectable only in the RA synovial lining layer, whereas extracellular DNA was detectable in various areas of synovial tissue. In vitro, exRNA (150-5000 nt) was released by RA synovial fibroblasts (RASF) under hypoxic conditions but not under normoxia or TNF-α treatment. RNase activity was increased in synovial fluid from RA and OA patients compared with psoriatic arthritis patients, whereas RNase activity of RASF and OASF cultures was not altered by hypoxia. Reduction of exRNA by RNase1 treatment decreased adhesion of RASF to cartilage, but it had no influence on their cell proliferation or adhesion to endothelial cells. In vivo, treatment with RNase1 reduced RASF invasion into coimplanted cartilage in the SCID mouse model of RA. We also analyzed the expression of neuropilins in synovial tissue and SF, as they may interact with vascular endothelial growth factor signaling and exRNA. The data support the concepts that the exRNA/RNase1 system participates in RA pathophysiology and that RASF are influenced by exRNA in a prodestructive manner.
Keyphrases
- rheumatoid arthritis
- disease activity
- endothelial cells
- ankylosing spondylitis
- vascular endothelial growth factor
- interstitial lung disease
- end stage renal disease
- newly diagnosed
- mouse model
- cell proliferation
- prognostic factors
- systemic lupus erythematosus
- peritoneal dialysis
- knee osteoarthritis
- systemic sclerosis
- signaling pathway
- machine learning
- combination therapy
- cell cycle
- patient reported outcomes
- electronic health record
- data analysis
- mass spectrometry
- biofilm formation
- pseudomonas aeruginosa
- circulating tumor cells
- patient reported